These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18592955)

  • 1. [Is resting heart rate a cardiovascular risk factor?].
    Cook S; Delacrétaz E; Hess OM
    Praxis (Bern 1994); 2008 May; 97(11):601-11. PubMed ID: 18592955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of heart rate reduction in heart failure.
    Hasenfuss G
    Curr Heart Fail Rep; 2010 Dec; 7(4):156-8. PubMed ID: 20924801
    [No Abstract]   [Full Text] [Related]  

  • 3. Advances in the management of heart failure: the role of ivabradine.
    Müller-Werdan U; Stöckl G; Werdan K
    Vasc Health Risk Manag; 2016; 12():453-470. PubMed ID: 27895488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease.
    Ferrari R; Ceconi C
    Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):959-73. PubMed ID: 21878041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heart failure].
    Merx MW; Ertl G
    Dtsch Med Wochenschr; 2011 Apr; 136(14):700-2. PubMed ID: 21448830
    [No Abstract]   [Full Text] [Related]  

  • 6. [Heart rate: a risk factor or an epiphenomenon?].
    Metra M; Zacà V; Lombardi C; Bugatti S; Dei Cas L
    G Ital Cardiol (Rome); 2010 Mar; 11(3):209-20. PubMed ID: 20550061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Resting heart rate as prognostic parameter--a slow rate indicates strength].
    Füessl HS
    MMW Fortschr Med; 2008 May; 150(21):12-4, 16. PubMed ID: 18575247
    [No Abstract]   [Full Text] [Related]  

  • 8. [Possibilities of reducing heart rate by I(f)-channel inhibitors].
    Hennersdorf MG
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():150-2. PubMed ID: 16802542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine.
    Vizzardi E; Bonadei I; D'Aloia A; Del Magro F; Piovanelli B; Bontempi L; Curnis A; Dei Cas L
    Minerva Med; 2011 Oct; 102(5):373-9. PubMed ID: 22193347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart rate and cardiovascular protection.
    Caetano J; Delgado Alves J
    Eur J Intern Med; 2015 May; 26(4):217-22. PubMed ID: 25704330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [From results of BEAUTIFUL trial to results of SHIFT trial: BEAUTIFUL possibility to make a SHIFT in current guidelines].
    Lopatin IuM
    Kardiologiia; 2011; 51(5):85-90. PubMed ID: 21649600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arrhythmia risk stratification based on clinical and functional data].
    Rostagno C; Lazzeri C; Gensini GF
    Ital Heart J Suppl; 2001 Dec; 2(12):1270-7. PubMed ID: 11838347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of beta-blockers in preventing sudden death in heart failure.
    Teerlink JR; Massie BM
    J Card Fail; 2000 Jun; 6(2 Suppl 1):25-33. PubMed ID: 10908095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of sudden cardiac death in patients with heart failure.
    Houmsse M; Franco V; Abraham WT
    Heart Fail Clin; 2011 Apr; 7(2):147-55, vii. PubMed ID: 21439494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden cardiac death in heart failure with preserved ejection fraction: a target for therapy?
    Vaduganathan M; Patel RB; Shah SJ; Butler J
    Heart Fail Rev; 2016 Jul; 21(4):455-62. PubMed ID: 26762335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate turbulence predicts all-cause mortality and sudden death in congestive heart failure patients.
    Cygankiewicz I; Zareba W; Vazquez R; Vallverdu M; Gonzalez-Juanatey JR; Valdes M; Almendral J; Cinca J; Caminal P; de Luna AB;
    Heart Rhythm; 2008 Aug; 5(8):1095-1102. PubMed ID: 18675217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators.
    Cleland JG; Erhardt L; Murray G; Hall AS; Ball SG
    Eur Heart J; 1997 Jan; 18(1):41-51. PubMed ID: 9049514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sudden cardiovascular death following myocardial infarction: the importance of left ventricular systolic dysfunction and congestive heart failure.
    Abildstrom SZ; Ottesen MM; Rask-Madsen C; Andersen PK; Rosthøj S; Torp-Pedersen C; Køber L
    Int J Cardiol; 2005 Sep; 104(2):184-9. PubMed ID: 16168812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate in coronary syndromes and heart failure.
    Orso F; Baldasseroni S; Maggioni AP
    Prog Cardiovasc Dis; 2009; 52(1):38-45. PubMed ID: 19615492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.